LIGHTNING HEALTH LTD

LIGHTNING HEALTH LTD - Company Information

2022-04-012023-03-312023-03-31false11063972LIGHTNING HEALTH LTD2023-12-20iso4217:GBPxbrli:pure110639722022-04-01110639722023-03-31110639722022-04-012023-03-31110639722021-04-01110639722022-03-31110639722021-04-012022-03-3111063972bus:SmallEntities2022-04-012023-03-3111063972bus:AuditExempt-NoAccountantsReport2022-04-012023-03-3111063972bus:FullAccounts2022-04-012023-03-3111063972bus:PrivateLimitedCompanyLtd2022-04-012023-03-3111063972core:WithinOneYear2023-03-3111063972core:AfterOneYear2023-03-3111063972core:WithinOneYear2022-03-3111063972core:AfterOneYear2022-03-3111063972core:ShareCapital2023-03-3111063972core:SharePremium2023-03-3111063972core:RevaluationReserve2023-03-3111063972core:OtherReservesSubtotal2023-03-3111063972core:RetainedEarningsAccumulatedLosses2023-03-3111063972core:ShareCapital2022-03-3111063972core:SharePremium2022-03-3111063972core:RevaluationReserve2022-03-3111063972core:OtherReservesSubtotal2022-03-3111063972core:RetainedEarningsAccumulatedLosses2022-03-3111063972core:LandBuildings2023-03-3111063972core:PlantMachinery2023-03-3111063972core:Vehicles2023-03-3111063972core:FurnitureFittings2023-03-3111063972core:OfficeEquipment2023-03-3111063972core:NetGoodwill2023-03-3111063972core:IntangibleAssetsOtherThanGoodwill2023-03-3111063972core:ListedExchangeTraded2023-03-3111063972core:UnlistedNon-exchangeTraded2023-03-3111063972core:LandBuildings2022-03-3111063972core:PlantMachinery2022-03-3111063972core:Vehicles2022-03-3111063972core:FurnitureFittings2022-03-3111063972core:OfficeEquipment2022-03-3111063972core:NetGoodwill2022-03-3111063972core:IntangibleAssetsOtherThanGoodwill2022-03-3111063972core:ListedExchangeTraded2022-03-3111063972core:UnlistedNon-exchangeTraded2022-03-3111063972core:LandBuildings2022-04-012023-03-3111063972core:PlantMachinery2022-04-012023-03-3111063972core:Vehicles2022-04-012023-03-3111063972core:FurnitureFittings2022-04-012023-03-3111063972core:OfficeEquipment2022-04-012023-03-3111063972core:NetGoodwill2022-04-012023-03-3111063972core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3111063972core:ListedExchangeTraded2022-04-012023-03-3111063972core:UnlistedNon-exchangeTraded2022-04-012023-03-3111063972core:MoreThanFiveYears2022-04-012023-03-3111063972core:Non-currentFinancialInstruments2023-03-3111063972core:Non-currentFinancialInstruments2022-03-3111063972dpl:CostSales2022-04-012023-03-3111063972dpl:DistributionCosts2022-04-012023-03-3111063972core:LandBuildings2022-04-012023-03-3111063972core:PlantMachinery2022-04-012023-03-3111063972core:Vehicles2022-04-012023-03-3111063972core:FurnitureFittings2022-04-012023-03-3111063972core:OfficeEquipment2022-04-012023-03-3111063972dpl:AdministrativeExpenses2022-04-012023-03-3111063972core:NetGoodwill2022-04-012023-03-3111063972core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3111063972dpl:GroupUndertakings2022-04-012023-03-3111063972dpl:ParticipatingInterests2022-04-012023-03-3111063972dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3111063972core:ListedExchangeTraded2022-04-012023-03-3111063972dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3111063972core:UnlistedNon-exchangeTraded2022-04-012023-03-3111063972dpl:CostSales2021-04-012022-03-3111063972dpl:DistributionCosts2021-04-012022-03-3111063972core:LandBuildings2021-04-012022-03-3111063972core:PlantMachinery2021-04-012022-03-3111063972core:Vehicles2021-04-012022-03-3111063972core:FurnitureFittings2021-04-012022-03-3111063972core:OfficeEquipment2021-04-012022-03-3111063972dpl:AdministrativeExpenses2021-04-012022-03-3111063972core:NetGoodwill2021-04-012022-03-3111063972core:IntangibleAssetsOtherThanGoodwill2021-04-012022-03-3111063972dpl:GroupUndertakings2021-04-012022-03-3111063972dpl:ParticipatingInterests2021-04-012022-03-3111063972dpl:GroupUndertakingscore:ListedExchangeTraded2021-04-012022-03-3111063972core:ListedExchangeTraded2021-04-012022-03-3111063972dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-04-012022-03-3111063972core:UnlistedNon-exchangeTraded2021-04-012022-03-3111063972core:NetGoodwill2023-03-3111063972core:IntangibleAssetsOtherThanGoodwill2023-03-3111063972core:LandBuildings2023-03-3111063972core:PlantMachinery2023-03-3111063972core:Vehicles2023-03-3111063972core:FurnitureFittings2023-03-3111063972core:OfficeEquipment2023-03-3111063972core:AfterOneYear2023-03-3111063972core:WithinOneYear2023-03-3111063972core:ListedExchangeTraded2023-03-3111063972core:UnlistedNon-exchangeTraded2023-03-3111063972core:ShareCapital2023-03-3111063972core:SharePremium2023-03-3111063972core:RevaluationReserve2023-03-3111063972core:OtherReservesSubtotal2023-03-3111063972core:RetainedEarningsAccumulatedLosses2023-03-3111063972core:NetGoodwill2022-03-3111063972core:IntangibleAssetsOtherThanGoodwill2022-03-3111063972core:LandBuildings2022-03-3111063972core:PlantMachinery2022-03-3111063972core:Vehicles2022-03-3111063972core:FurnitureFittings2022-03-3111063972core:OfficeEquipment2022-03-3111063972core:AfterOneYear2022-03-3111063972core:WithinOneYear2022-03-3111063972core:ListedExchangeTraded2022-03-3111063972core:UnlistedNon-exchangeTraded2022-03-3111063972core:ShareCapital2022-03-3111063972core:SharePremium2022-03-3111063972core:RevaluationReserve2022-03-3111063972core:OtherReservesSubtotal2022-03-3111063972core:RetainedEarningsAccumulatedLosses2022-03-3111063972core:NetGoodwill2021-04-0111063972core:IntangibleAssetsOtherThanGoodwill2021-04-0111063972core:LandBuildings2021-04-0111063972core:PlantMachinery2021-04-0111063972core:Vehicles2021-04-0111063972core:FurnitureFittings2021-04-0111063972core:OfficeEquipment2021-04-0111063972core:AfterOneYear2021-04-0111063972core:WithinOneYear2021-04-0111063972core:ListedExchangeTraded2021-04-0111063972core:UnlistedNon-exchangeTraded2021-04-0111063972core:ShareCapital2021-04-0111063972core:SharePremium2021-04-0111063972core:RevaluationReserve2021-04-0111063972core:OtherReservesSubtotal2021-04-0111063972core:RetainedEarningsAccumulatedLosses2021-04-0111063972core:AfterOneYear2022-04-012023-03-3111063972core:WithinOneYear2022-04-012023-03-3111063972core:Non-currentFinancialInstrumentscore:CostValuation2022-04-012023-03-3111063972core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-04-012023-03-3111063972core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-04-012023-03-3111063972core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-04-012023-03-3111063972core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-04-012023-03-3111063972core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-04-012023-03-3111063972core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3111063972core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3111063972core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3111063972core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3111063972core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3111063972core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3111063972core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3111063972core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3111063972core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3111063972core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3111063972core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3111063972core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3111063972core:Non-currentFinancialInstrumentscore:CostValuation2022-03-3111063972core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-3111063972core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-3111063972core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-3111063972core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-3111063972core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-3111063972core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-3111063972core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-3111063972core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-3111063972bus:Director12022-04-012023-03-3111063972bus:Director22022-04-012023-03-3111063972bus:Director32022-04-012023-03-3111063972bus:Director42022-04-012023-03-31

Registered Number
11063972
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2023

LIGHTNING HEALTH LTD

Company Information
for the year from 1 April 2022 to 31 March 2023


Directors	Mr F D Alcraft
	Dr F J Paton
	Mr A W Satherley
	Mr J T Whitehouse


Registered Address	12 Tentercroft Street
	Lincoln
	LN5 7DB


Place of Business	8 Devonshire Square
	London
	EC2M 4YD


Registered Number	11063972 (England and Wales)

LIGHTNING HEALTH LTD

Balance Sheet as at
31 March 2023

	Notes	2023		2022
		£	£	£	£
Fixed assets
Intangible assets	7		2,158		2,539
Tangible assets	8		6,980		9,014
			9,138		11,553
Current assets
Debtors	9	334,152		184,424
Cash at bank and on hand		179,031		66,715
		513,183		251,139
Creditors amounts falling due within one year	10	(530,605)		(373,663)
Net current assets (liabilities)			(17,422)		(122,524)
Total assets less current liabilities			(8,284)		(110,971)
Creditors amounts falling due after one year	11		(265,797)		(180,697)
Net assets			(274,081)		(291,668)
Capital and reserves
Called up share capital			4		4
Share premium			99,998		99,998
Profit and loss account			(374,083)		(391,670)
Shareholders' funds			(274,081)		(291,668)

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. The directors have chosen to not file a copy of the company’s profit and loss account.

The financial statements were approved and authorised for issue by the Board of Directors on 20 December 2023, and are signed on its behalf by:

Mr J T Whitehouse
Director
Registered Company No. 11063972

LIGHTNING HEALTH LTD

Notes to the Financial Statements
for the year ended 31 March 2023

1.	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	Compliance with applicable reporting framework
	The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

3.	Principal activities
	The principal activity of the company is market research and consultancy

4.	Basis of measurement used in financial statements
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

5.	Accounting policies

	Turnover policy
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

	Property, plant and equipment policy
	Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:


		Straight line (years)
	Office Equipment	3

	Intangible assets policy
	Intangible assets are stated in the statement of financial position at cost, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. The cost of intangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

	Revenue recognition policy
	Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

Revenue recognition policy

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Taxation policy
	Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

	Foreign currency translation and operations policy
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

Foreign currency translation and operations policy

Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

	Employee benefits policy
	Contributions to defined contribution plans are expensed in the period to which they relate.

	Going concern
	The financial statements have been prepared on a going concern basis. This is based on the continued financial support of the Directors.

6.	Employee information


		2023		2022
	Average number of employees during the year	13		11

7.	Intangible assets

	Other	Total
	£	£
Cost or valuation
At 01 April 22	3,808	3,808
At 31 March 23	3,808	3,808
Amortisation and impairment
At 01 April 22	1,269	1,269
Charge for year	381	381
At 31 March 23	1,650	1,650
Net book value
At 31 March 23	2,158	2,158
At 31 March 22	2,539	2,539

8.	Property, plant and equipment

	Office Equipment	Total
	£	£
Cost or valuation
At 01 April 22	15,662	15,662
Additions	2,872	2,872
At 31 March 23	18,534	18,534
Depreciation and impairment
At 01 April 22	6,648	6,648
Charge for year	4,906	4,906
At 31 March 23	11,554	11,554
Net book value
At 31 March 23	6,980	6,980
At 31 March 22	9,014	9,014

9.	Debtors

	2023	2022
	£	£
Trade debtors / trade receivables	259,466	128,079
Other debtors	44,502	47,535
Prepayments and accrued income	30,184	8,810
Total	334,152	184,424


	Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

10.	Creditors within one year

	2023	2022
	£	£
Trade creditors / trade payables	58,321	118,774
Bank borrowings and overdrafts	9,747	10,000
Taxation and social security	22,127	41,521
Other creditors	16,304	10,871
Accrued liabilities and deferred income	424,106	192,497
Total	530,605	373,663


	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

11.	Creditors after one year

	2023	2022
	£	£
Bank borrowings and overdrafts	30,747	40,000
Other creditors	235,050	140,697
Total	265,797	180,697


	Bank borrowings Bounce back loan is denominated in £ with a nominal interest rate of 2.5%, and the final instalment is due on 23 March 2027. The carrying amount at year end is £40,494 (2022 - £50,000). Other borrowings Other borrowings is denominated in £ with a nominal interest rate of 8% above market rate. The carrying amount at year end is £235,050 (2022 - £140,697). The other borrowings are secured by fixed and floating charges over the assets of the company.

Bank borrowings
Bounce back loan is denominated in £ with a nominal interest rate of 2.5%, and the final instalment is due on 23 March 2027. The carrying amount at year end is £40,494 (2022 - £50,000).

Other borrowings
Other borrowings is denominated in £ with a nominal interest rate of 8% above market rate. The carrying amount at year end is £235,050 (2022 - £140,697).
The other borrowings are secured by fixed and floating charges over the assets of the company.